DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFNBusiness Wire • 04/01/23
DFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to ShareholdersBusiness Wire • 03/30/23
EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative DiseasesGlobeNewsWire • 03/30/23
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special OpportunitiesGlobeNewsWire • 12/16/22
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci's History of Stockholder Value Destruction and Self-DealingGlobeNewsWire • 12/05/22
Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/14/22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review ProcessGlobeNewsWire • 11/14/22
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSCGlobeNewsWire • 10/25/22
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/11/22
Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor OxygenationGlobeNewsWire • 07/26/22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory OfficerGlobeNewsWire • 05/18/22
Diffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 05/17/22
Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing RequirementsGlobeNewsWire • 05/04/22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance PlanGlobeNewsWire • 04/18/22
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of StockholdersGlobeNewsWire • 04/08/22
Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 03/21/22